How severe is CVE-2025-30042?

CVE-2025-30042 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2025-30042 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (1st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2025-30042?

CVE-2025-30042 affects Cgm Clininet. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2025-30042?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

Does CVE-2025-30042 have an EU (EUVD) identifier?

Yes. CVE-2025-30042 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-208147.

When was CVE-2025-30042 published?

CVE-2025-30042 was published on 2026-03-02 and last updated on 2026-06-17.

CVE-2025-30042

CVE-2025-30042 is a high-severity vulnerability in Cgm Clininet with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-603.

Key facts

Severity: High (CVSS 3.x base score 7.8)
CVSS v4: 9.0
EPSS exploit prediction: 0% (1st percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-208147
Weakness: CWE-603
Affected product: Cgm Clininet
Published: 2026-03-02
Last modified: 2026-06-17

Description

The CGM CLININET system provides smart card authentication; however, authentication is conducted locally on the client device, and, in reality, only the certificate number is used for access verification. As a result, possession of the certificate number alone is sufficient for authentication, regardless of the actual presence of the smart card or ownership of the private key.

Frequently asked questions

What is CVE-2025-30042?: The CGM CLININET system provides smart card authentication; however, authentication is conducted locally on the client device, and, in reality, only the certificate number is used for access verification. As a result, possession of the certificate number alone is sufficient for authentication, regardless of the actual presence of the smart card or ownership of the private key.
How severe is CVE-2025-30042?: CVE-2025-30042 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2025-30042 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (1st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-30042?: CVE-2025-30042 affects Cgm Clininet. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-30042?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-30042 have an EU (EUVD) identifier?: Yes. CVE-2025-30042 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-208147.
When was CVE-2025-30042 published?: CVE-2025-30042 was published on 2026-03-02 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:cgm:clininet:*:*:*:*:*:*:*:*

More vulnerabilities in Cgm Clininet

CVE-2025-58402 — High (CVSS 7.5): The CGM CLININET application uses direct, sequential object identifiers "MessageID" without proper authorization…
CVE-2025-58405 — Medium (CVSS 6.1): The CGM CLININET application does not implement any mechanisms that prevent clickjacking attacks, neither HTTP security…
CVE-2025-58406 — Medium (CVSS 4.3): The CGM CLININET application respond without essential security HTTP headers, exposing users to client‑side attacks…

All CVEs affecting Cgm Clininet →

Other CWE-603 vulnerabilities

CVE-2026-1363 — Critical (CVSS 9.8): IAQS and I6 developed by JNC has a Client-Side Enforcement of Server-Side Security vulnerability, allowing…
CVE-2025-12868 — Critical (CVSS 9.8): New Site Server developed by CyberTutor has a Use of Client-Side Authentication vulnerability, allowing unauthenticated…
CVE-2024-39375 — Critical (CVSS 9.8): TELSAT marKoni FM Transmitters are vulnerable to an attacker bypassing authentication and gaining administrator…
CVE-2022-33139 — Critical (CVSS 9.8): A vulnerability has been identified in Cerberus DMS (All versions), Desigo CC (All versions), Desigo CC Compact (All…
CVE-2025-64119 — Critical (CVSS 9.3): A vulnerability in Nuvation Battery Management System allows Authentication Bypass.This issue affects Battery…
CVE-2020-7591 — High (CVSS 8.8): A vulnerability has been identified in SIPORT MP (All versions < 3.2.1). Vulnerable versions of the device could allow…

Browse all CWE-603 vulnerabilities →